GENE ONLINE|News &
Opinion
Blog

Remdesivir
Remdesivir Cleared for Treating Non-Hospitalized COVID-19 Patients
2022-01-24
As India Suffers Crisis, Merck Signs License Pact with 5 Indian Firms to Manufacture COVID-19 Drugs
2021-04-29
A 11-Year-Old, Survivor-Derived Antibody Becomes Second Ebola Therapy to Bag FDA Approval
2020-12-23
First to the Finish Line! Remdesivir Becomes the First and Only FDA Approved Drug to Treat COVID-19
2020-10-23
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
Dexamethasone Renews Hopes for a Life Saving COVID-19 Treatment
2020-06-20
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
Coronavirus Drugs: Studies Show Remdesivir’s Activity against Viral Enzyme
2020-04-15
Remdesivir’s Early Trial Data Necessitates Guarded Optimism
2020-04-12
Gilead Requests FDA to Rescind Remdesivir’s Orphan Drug Designation
2020-03-25
Gilead’s Remdesivir Wins FDA’s Orphan Drug Designation for COVID-19 Treatment
2020-03-24
Taiwan’s Action Strategies Provide Great Model to Fight Coronavirus
2020-03-16
COVID-19 Victims on Remdesivir Treatment Hopeful after First US Patient Recovers
2020-03-12
1 2
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!